All Posts By

Ehave

CEO Update Going into 2020

By | Press Releases
Digital Therapeutics Market to Exceed $32 Billion by 2024 Offering Mixed Fortunes for Drug Companies Five‌ ‌years‌ ‌ago, ‌I‌ ‌was‌ ‌an‌ ‌eager‌ ‌investor‌ ‌writing‌ ‌one‌ ‌of‌ ‌the‌ ‌first‌ ‌checks‌ ‌to‌ ‌capitalize‌ ‌a‌ ‌new‌ ‌company‌ ‌named‌ ‌Ehave.‌ ‌Now,‌ ‌I‌ ‌am‌ ‌introducing‌...
Read More

Ehave to Explore Strategic Alternatives

By | Press Releases
Ehave, Inc. (OTCQB: EHVVF), a healthcare company dedicated to empowering the medical cannabis and mental health communities with next-generation digital solutions, announced today that its Board of Directors, supported by its management team, has engaged in a process of exploring...
Read More

CHILD-BRIGHT Network and Ehave Start Enrollment for Cognitive Rehabilitation Trial for Children with ADHD, Autism, and Congenital Heart Disease

By | MegaTeam, Press Releases
The CHILD-BRIGHT Mega Team game is an innovative video game-based cognitive intervention that aims to improve executive functions in children with brain-based developmental disabilities. The CHILD-BRIGHT Network, a Canadian patient-oriented research network focused on pediatric brain-based developmental disorders, and Ehave,...
Read More

Aequus and Ehave Enter into Collaboration Agreement for Comprehensive Patient Data Management in Clinical Trials of Medical Cannabis

By | Medical Cannabis, Press Releases
Ehave’s Bioinformatics Platform Technology to Be Used to Evaluate Aequus’ Products in Multiple Neurological Disorders Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products,...
Read More